{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:33:28Z","timestamp":1789173208570,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020655","name":"European Health and Digital Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.eclinm.2026.103865","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:38:48Z","timestamp":1775896728000},"page":"103865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effectiveness, immunogenicity and safety of human papillomavirus vaccination in non-HIV immunocompromised individuals: a systematic review"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-4605","authenticated-orcid":false,"given":"Philipp","family":"Kapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Siemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Gorenflo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"R\u00f6bl-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Askar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Brotons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Henrik","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Konopnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judi","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ru\u0163\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Saare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Swennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tachezy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Takla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"U\u010dakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simopekka","family":"V\u00e4nsk\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-3763","authenticated-orcid":false,"given":"Dace","family":"Zavadska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam Adel","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-2470","authenticated-orcid":false,"given":"Kate","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg J.","family":"Meerpohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.eclinm.2026.103865_bib1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur J Cancer"},{"issue":"50","key":"10.1016\/j.eclinm.2026.103865_bib2","first-page":"645","article-title":"Human papillomavirus vaccines: WHO position paper, December 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"10451","key":"10.1016\/j.eclinm.2026.103865_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103865_bib4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.eclinm.2026.103865_bib5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103865_bib6","series-title":"Human Papillomavirus Infection: Recommended Vaccinations","year":"2024"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103865_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103865_bib8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/cid\/ciac285","article-title":"Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls","volume":"75","author":"Larsen","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103865_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(24)00189-X","article-title":"Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis","volume":"25","author":"Jin","year":"2024","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103865_bib10","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/ijc.32565","article-title":"Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: a Danish nationwide, registry-based cohort study","volume":"146","author":"Reinholdt","year":"2020","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103865_bib11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/annrheumdis-2013-204993","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103865_bib12","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the United States","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103865_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9581","key":"10.1016\/j.eclinm.2026.103865_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103865_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10067-010-1606-0","article-title":"Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review","volume":"30","author":"Santana","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.eclinm.2026.103865_bib16","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"23","key":"10.1016\/j.eclinm.2026.103865_bib17","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103865_bib18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.103865_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101585","article-title":"Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: a systematic review and meta-analysis","volume":"52","author":"Staadegaard","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103865_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/21645515.2019.1656481","article-title":"A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus","volume":"16","author":"Mavundza","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103865_bib21","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1038\/s41598-021-83727-7","article-title":"Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"11","author":"Zizza","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2026.103865_bib22","article-title":"Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?","volume":"4","author":"Vinkenes","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"issue":"30","key":"10.1016\/j.eclinm.2026.103865_bib23","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1016\/j.vaccine.2015.05.041","article-title":"Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: a systematic review","volume":"33","author":"Pellegrino","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.103865_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","article-title":"HPV vaccination of immunocompromised hosts","volume":"4","author":"Garland","year":"2017","journal-title":"Papillomavirus Res"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103865_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14760584.2021.1889375","article-title":"Systematic review and meta-analysis of HPV vaccination in women with systemic lupus erythematosus (SLE)","volume":"20","author":"Infante","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eclinm.2026.103865_bib26","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103865_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103865_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","article-title":"GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines","volume":"142","author":"Cuello-Garcia","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103865_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jclinepi.2022.08.015","article-title":"Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program","volume":"152","author":"Saldanha","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103865_bib30","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103865_bib31","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 14: completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2023"},{"key":"10.1016\/j.eclinm.2026.103865_bib32","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.eclinm.2026.103865_bib33","series-title":"A Language and Environment for Statistical Computing","year":"2020"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103865_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103865_bib35","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/sim.791","article-title":"On tests of the overall treatment effect in meta-analysis with normally distributed responses","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"24","key":"10.1016\/j.eclinm.2026.103865_bib36","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103865_bib37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12535","article-title":"Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study","volume":"280","author":"Gr\u00f6nlund","year":"2016","journal-title":"J Intern Med"},{"issue":"29","key":"10.1016\/j.eclinm.2026.103865_bib38","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2020.05.004","article-title":"Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women","volume":"38","author":"Silverberg","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.103865_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fped.2020.00046","article-title":"Human papillomavirus vaccination in male and female adolescents before and after kidney transplantation: a pediatric nephrology research consortium study","volume":"8","author":"Nailescu","year":"2020","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103865_bib40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2215\/CJN.09690915","article-title":"Immunogenicity of human papillomavirus recombinant vaccine in children with CKD","volume":"11","author":"Nelson","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.eclinm.2026.103865_bib41","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2017.04.001","article-title":"The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus","volume":"35","author":"Dhar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.103865_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1452916","article-title":"Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant","volume":"14","author":"Miyaji","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103865_bib43","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1586\/14760584.2014.943195","article-title":"Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis","volume":"13","author":"Esposito","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103865_bib44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/petr.12226","article-title":"Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients","volume":"18","author":"Gomez-Lobo","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103865_bib45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0961203320928406","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study","volume":"29","author":"Grein","year":"2020","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103865_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12969-020-00479-w","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study","volume":"18","author":"Grein","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103865_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/annrheumdis-2013-203429","article-title":"Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study","volume":"73","author":"Heijstek","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103865_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b","article-title":"Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease","volume":"19","author":"Jacobson","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103865_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14476","article-title":"Immunogenicity of a quadrivalent human papillomavirus vaccine in pediatric kidney and liver transplant recipients","volume":"27","author":"Kitano","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103865_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2352-4642(21)00278-9","article-title":"Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial","volume":"6","author":"Landier","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103865_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103865_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaoncol.2019.6722","article-title":"Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant: a nonrandomized clinical trial","volume":"6","author":"Stratton","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103865_bib53","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.vaccine.2013.11.048","article-title":"Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes","volume":"32","author":"Alter","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103865_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13061368","article-title":"Human papillomavirus oral-and sero-positivity in Fanconi anemia","volume":"13","author":"Sauter","year":"2021","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.eclinm.2026.103865_bib55","doi-asserted-by":"crossref","first-page":"E648","DOI":"10.1503\/cmaj.170871","article-title":"Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study","volume":"190","author":"Liu","year":"2018","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103865_bib56","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1093\/cid\/ciaa1897","article-title":"Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with Human Immunodeficiency Virus (HIV)","volume":"73","author":"Boey","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103865_bib57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ndt\/gfv444","article-title":"Immunogenicity and safety of quadrivalent human papillomavirus types 6\/11\/16\/18 recombinant vaccine in chronic kidney disease stage IV, V and VD","volume":"32","author":"Praditpornsilpa","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103865_bib58","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"issue":"37","key":"10.1016\/j.eclinm.2026.103865_bib59","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1016\/j.vaccine.2019.07.072","article-title":"Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children","volume":"37","author":"MacIntyre","year":"2019","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.eclinm.2026.103865_bib60","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2016.06.049","article-title":"Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children","volume":"34","author":"MacIntyre","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.103865_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"32 Pt A","key":"10.1016\/j.eclinm.2026.103865_bib62","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: serology assays and their use in HPV vaccine evaluation and development","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103865_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011403","article-title":"The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays","volume":"19","author":"Park","year":"2023","journal-title":"PLoS Pathog"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:05:54Z","timestamp":1778904354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026001124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"alternative-id":["S2589537026001124"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103865","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness, immunogenicity and safety of human papillomavirus vaccination in non-HIV immunocompromised individuals: a systematic review","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103865"}}